Working… Menu
Help guide our efforts to modernize
Send us your comments by March 14, 2020.

Study of PPI-668, BI 207127 and Faldaprevir, With and Without Ribavirin, in the Treatment of Chronic Hepatitis C

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01859962
Recruitment Status : Completed
First Posted : May 22, 2013
Last Update Posted : November 25, 2015
Boehringer Ingelheim
Information provided by (Responsible Party):
Presidio Pharmaceuticals, Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : May 2014
Actual Study Completion Date : December 2014
Certification/Extension First Submitted : October 20, 2015